ARGEN Brochure: Protein Stability Monitoring ARGEN by Fluence Analytics is the right instrument to assess the stability of therapeutic biopolymers and natural polymer products. ARGEN users can conduct up to 16 independent experiments simultaneously. ARGEN generates real-time, continuous data throughout each experiment, yielding extremely valuable kinetic sample stability data. ARGEN’s 16 cuvette sample holders are...Read More
New Instrument Continuously Analyzes Protein and Natural Polymer Aggregation (New Orleans, LA, U.S.) ‒ Fluence Analytics, a manufacturer of realtime, industrial and laboratory monitoring systems, today announced the launch of ARGEN, a patented protein and polymer stability monitoring product. By utilizing continuous light scattering measurements, ARGEN yields a unique information stream which reduces discovery and...Read More
Protein aggregation has presented biopharmaceutical scientists with constant difficulties during formulation development. Historically, batch-based methods such as SEC, HPLC and other aggregation detectors offer incomplete solutions because they do not provide scientists with realtime kinetic data on protein stability nor insight into the mechanisms of protein aggregation. ARGEN, an instrument by Fluence Analytics, adds a powerful tool to the protein scientist’s arsenal. ARGEN is a light scattering instrument...Read More
Michael Drenski, CTO of Fluence Analytics, is attending AMI’s first Polymer Testing & Analysis 2017 Conference at the Pittsburgh Marriott City Center, and he will present data from using ARGEN to monitor and characterize polymer degradation of polystyrene. Michael’s talk is scheduled for Session 5 on Wednesday, September 20 at 9:10 a.m. ARGEN is a light scattering instrument...Read More
A critical component of the biopharmaceutical development process is the creation of a formulation to protect proteins from various mechanical and thermal stressors that occur during manufacturing, storage and transport. In non-optimized formulations, stressors cause protein degradation which can render the biopharmaceutical ineffective and possibly harmful to patients. For this reason, researchers are starting to...Read More
Biopharmaceutical companies isolate many types of proteins for use in experimental and therapeutic medicines. Unfortunately, when removed from their native environments, proteins become less stable. Unstable proteins are more prone to degradation from the primary stress mechanisms: mechanical and thermal (from manufacturing, storage and transport) and biological (from drug delivery). The challenge for biopharmaceutical companies...Read More
(New Orleans, LA, U.S.) ‒ Advanced Polymer Monitoring Technologies (APMT) today announced that a European business development professional has joined its team. Bernhard Bartylla will lead European initiatives for APMT’s product lines serving polymer and biopharmaceutical applications. “We’re working with Bernhard to introduce ACOMP and ARGEN to European manufacturers and researchers. Bernhard brings significant experience...Read More
Leading Healthcare Venture Capitalist and Immunology Expert Brings Valuable Experience to APMT (New Orleans, LA, U.S.) ‒ Advanced Polymer Monitoring Technologies (APMT) today announced the appointment of Dr. Arnold Oronsky to its Technical Advisory Board. Dr. Oronsky is a Managing Director at InterWest Partners. He holds a Ph.D. in immunology from Columbia University and has published more than...Read More
New Study Involves Increased Protein Stability Using APMT’s ARGEN Product (New Orleans, LA, U.S.) ‒ Advanced Polymer Monitoring Technologies (APMT) has partnered with Dr. Danny Chou of Compassion BioSolution, LLC and other researchers on a multi-collaborator study involving various measurement techniques, including APMT’s ARGEN product. Dr. Chou will present the results of this study on August 15-16,...Read More
(New Orleans, LA, U.S.) ‒ Advanced Polymer Monitoring Technologies, Inc. recently completed construction of over 600 square feet of applications engineering and R&D labs to engage in projects with customers and support internal research and development efforts. The facilities are outfitted with APMT’s ACOMP and ARGEN products along with other standard instrumentation. Alex Reed, APMT Chief Executive Officer...Read More